{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T06:05:30Z","timestamp":1775369130234,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Serine\/threonine phosphorylation of insulin receptor substrate (IRS) proteins is well known to modulate insulin signaling. However, the molecular details of this process have mostly been elusive. While exploring the role of phosphoserines, we have detected a direct link between Tyr-flanking Ser\/Thr phosphorylation sites and regulation of specific phosphotyrosine phosphatases. Here we present a concise structural study on how the activity of SHP2 phosphatase is controlled by an asymmetric, dual phosphorylation of its substrates. The structure of SHP2 has been determined with three different substrate peptides, unveiling the versatile and highly dynamic nature of substrate recruitment. What is more, the relatively stable pre-catalytic state of SHP2 could potentially be useful for inhibitor design. Our findings not only show an unusual dependence of SHP2 catalytic activity on Ser\/Thr phosphorylation sites in IRS1 and CD28, but also suggest a negative regulatory mechanism that may also apply to other tyrosine kinase pathways as well.<\/jats:p>","DOI":"10.1038\/s41467-022-32918-5","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T11:04:00Z","timestamp":1663326240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structural insights into the pSer\/pThr dependent regulation of the SHP2 tyrosine phosphatase in insulin and CD28 signaling"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5229-8617","authenticated-orcid":false,"given":"Andr\u00e1s","family":"Zeke","sequence":"first","affiliation":[]},{"given":"Tam\u00e1s","family":"Tak\u00e1cs","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8963-8163","authenticated-orcid":false,"given":"P\u00e9ter","family":"Sok","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-7648","authenticated-orcid":false,"given":"Krisztina","family":"N\u00e9meth","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-4473","authenticated-orcid":false,"given":"Kl\u00e1ra","family":"Kirsch","sequence":"additional","affiliation":[]},{"given":"P\u00e9ter","family":"Egri","sequence":"additional","affiliation":[]},{"given":"\u00c1d\u00e1m Levente","family":"P\u00f3ti","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Bento","sequence":"additional","affiliation":[]},{"given":"G\u00e1bor E.","family":"Tusn\u00e1dy","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-1311","authenticated-orcid":false,"given":"Attila","family":"Rem\u00e9nyi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"32918_CR1","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","volume":"55","author":"KD Copps","year":"2012","unstructured":"Copps, K. D. & White, M. F. Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55, 2565\u20132582 (2012).","journal-title":"Diabetologia"},{"key":"32918_CR2","doi-asserted-by":"crossref","unstructured":"Ikink, G.J., Boer, M., Bakker, E.R.M. & Hilkens, J. IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K\/AKT-pathway hyperactivation. Nat. Commun. 7, 13567 (2016).","DOI":"10.1038\/ncomms13567"},{"key":"32918_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","volume":"14","author":"K Rabe","year":"2008","unstructured":"Rabe, K., Lehrke, M., Parhofer, K. G. & Broedl, U. C. Adipokines and insulin resistance. Mol. Med. 14, 741\u2013751 (2008).","journal-title":"Mol. Med."},{"key":"32918_CR4","doi-asserted-by":"publisher","first-page":"12467","DOI":"10.1074\/jbc.M114.554162","volume":"289","author":"NJ Han\u00e7er","year":"2014","unstructured":"Han\u00e7er, N. J. et al. Insulin and metabolic stress stimulate multisite serine\/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. J. Biol. Chem. 289, 12467\u201312484 (2014).","journal-title":"J. Biol. Chem."},{"key":"32918_CR5","doi-asserted-by":"crossref","unstructured":"Choi, E. et al. Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling. Nat. Commun. 10, 1473 (2019).","DOI":"10.1038\/s41467-019-09318-3"},{"key":"32918_CR6","doi-asserted-by":"publisher","first-page":"26908","DOI":"10.1074\/jbc.273.41.26908","volume":"273","author":"MG Myers","year":"1998","unstructured":"Myers, M. G. et al. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP\u22122 and negatively regulate insulin signaling. J. Biol. Chem. 273, 26908\u201326914 (1998).","journal-title":"J. Biol. Chem."},{"key":"32918_CR7","doi-asserted-by":"crossref","unstructured":"Marasco, M. et al. Molecular mechanism of SHP2 activation by PD-1 stimulation. Sci. Adv. 6, (2020).","DOI":"10.1126\/sciadv.aay4458"},{"key":"32918_CR8","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1074\/jbc.RA119.011422","volume":"295","author":"Z Hartman","year":"2020","unstructured":"Hartman, Z., Geldenhuys, W. J. & Agazie, Y. M. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2). J. Biol. Chem. 295, 3563\u20133575 (2020).","journal-title":"J. Biol. Chem."},{"key":"32918_CR9","doi-asserted-by":"crossref","unstructured":"Kano, Y. et al. Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation. Nat. Commun. 10, 224 (2019).","DOI":"10.1038\/s41467-018-08115-8"},{"key":"32918_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1182\/blood-2018-11-844688","volume":"133","author":"CM Niemeyer","year":"2019","unstructured":"Niemeyer, C. M. & Flotho, C. Juvenile myelomonocytic leukemia: Who\u2019s the driver at the wheel? Blood 133, 1060\u20131070 (2019).","journal-title":"Blood"},{"key":"32918_CR11","doi-asserted-by":"publisher","first-page":"15376","DOI":"10.1073\/pnas.0702555104","volume":"104","author":"U Schaeper","year":"2007","unstructured":"Schaeper, U. et al. Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo. Proc. Natl Acad. Sci. U. S. A. 104, 15376\u201315381 (2007).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"32918_CR12","doi-asserted-by":"publisher","first-page":"11222","DOI":"10.1074\/jbc.271.19.11222","volume":"271","author":"I Mothe","year":"1996","unstructured":"Mothe, I. & Van Obberghen, E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271, 11222\u201311227 (1996).","journal-title":"J. Biol. Chem."},{"key":"32918_CR13","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512\u2013D520 (2015).","journal-title":"Nucleic Acids Res."},{"key":"32918_CR14","doi-asserted-by":"publisher","first-page":"13952","DOI":"10.1074\/jbc.M210670200","volume":"278","author":"YM Agazie","year":"2003","unstructured":"Agazie, Y. M. & Hayman, M. J. Development of an efficient \u2018substrate-trapping\u2019 mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. J. Biol. Chem. 278, 13952\u201313958 (2003).","journal-title":"J. Biol. Chem."},{"key":"32918_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/MCB.25.2.819-829.2005","volume":"25","author":"S Galic","year":"2005","unstructured":"Galic, S. et al. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol. Cell. Biol. 25, 819\u2013829 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"32918_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","volume":"280","author":"T Tiganis","year":"2013","unstructured":"Tiganis, T. PTP1B and TCPTP - Nonredundant phosphatases in insulin signaling and glucose homeostasis. FEBS J. 280, 445\u2013458 (2013).","journal-title":"FEBS J."},{"key":"32918_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1210\/en.2007-0908","volume":"149","author":"S Aga-Mizrachi","year":"2008","unstructured":"Aga-Mizrachi, S. et al. Cytosolic protein tyrosine phosphatase-\u03b5 is a negative regulator of insulin signaling in skeletal muscle. Endocrinology 149, 605\u2013614 (2008).","journal-title":"Endocrinology"},{"key":"32918_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S1097-2765(00)00137-4","volume":"6","author":"A Salmeen","year":"2000","unstructured":"Salmeen, A., Andersen, J. N., Myers, M. P., Tonks, N. K. & Barford, D. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol. Cell 6, 1401\u20131412 (2000).","journal-title":"Mol. Cell"},{"key":"32918_CR19","doi-asserted-by":"crossref","unstructured":"LaRochelle, J.R. et al. Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition. Nat. Commun. 9, 4508 (2018).","DOI":"10.1038\/s41467-018-06823-9"},{"key":"32918_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","volume":"355","author":"E Hui","year":"2017","unstructured":"Hui, E. et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 355, 1428\u20131433 (2017).","journal-title":"Science"},{"key":"32918_CR21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2015.357","volume":"30","author":"J Rohr","year":"2016","unstructured":"Rohr, J. et al. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. Leukemia 30, 1062\u20131070 (2016).","journal-title":"Leukemia"},{"key":"32918_CR22","doi-asserted-by":"crossref","unstructured":"Vemulapalli, V. et al. Time resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of shp2-dependent signaling. Elife 10, e64251 (2021).","DOI":"10.7554\/eLife.64251"},{"key":"32918_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/bi401223r","volume":"53","author":"NG Selner","year":"2014","unstructured":"Selner, N. G. et al. Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases. Biochemistry 53, 397\u2013412 (2014).","journal-title":"Biochemistry"},{"key":"32918_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.str.2015.01.017","volume":"23","author":"EK Chen","year":"2015","unstructured":"Chen, E. K. et al. Substrate specificity and plasticity of FERM-containing protein tyrosine phosphatases. Structure 23, 653\u2013664 (2015).","journal-title":"Structure"},{"key":"32918_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2008.11.038","volume":"136","author":"AJ Barr","year":"2009","unstructured":"Barr, A. J. et al. Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136, 352\u2013363 (2009).","journal-title":"Cell"},{"key":"32918_CR26","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1021\/bi000319w","volume":"39","author":"M Sarmiento","year":"2000","unstructured":"Sarmiento, M. et al. Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition. Biochemistry 39, 8171\u20138179 (2000).","journal-title":"Biochemistry"},{"key":"32918_CR27","doi-asserted-by":"publisher","first-page":"13336","DOI":"10.1021\/bi801724n","volume":"47","author":"DA Critton","year":"2008","unstructured":"Critton, D. A., Tortajada, A., Stetson, G., Peti, W. & Page, R. Structural basis of substrate recognition by hematopoietic tyrosine phosphatase. Biochemistry 47, 13336\u201313345 (2008).","journal-title":"Biochemistry"},{"key":"32918_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1084\/jem.20041890","volume":"201","author":"HJ Nam","year":"2005","unstructured":"Nam, H. J., Poy, F., Saito, H. & Frederick, C. A. Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45. J. Exp. Med. 201, 441\u2013452 (2005).","journal-title":"J. Exp. Med."},{"key":"32918_CR29","first-page":"ra98","volume":"7","author":"KE Chen","year":"2014","unstructured":"Chen, K. E. et al. Reciprocal allosteric regulation of p38\u03b3 and PTPN3 involves a PDZ domain-modulated complex formation. Sci. Signal. 7, ra98 (2014).","journal-title":"Sci. Signal."},{"key":"32918_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.chembiol.2010.10.015","volume":"18","author":"S Liu","year":"2011","unstructured":"Liu, S. et al. SHP2 is a target of the immunosuppressant tautomycetin. Chem. Biol. 18, 101\u2013110 (2011).","journal-title":"Chem. Biol."},{"key":"32918_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1021\/acsmedchemlett.5b00118","volume":"6","author":"R He","year":"2015","unstructured":"He, R. et al. Exploring the existing drug space for novel pTyr mimetic and SHP2 inhibitors. ACS Med. Chem. Lett. 6, 782\u2013786 (2015).","journal-title":"ACS Med. Chem. Lett."},{"key":"32918_CR32","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1073\/pnas.0710468105","volume":"105","author":"K Hellmuth","year":"2008","unstructured":"Hellmuth, K. et al. Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking. Proc. Natl Acad. Sci. U. S. A. 105, 7275\u20137280 (2008).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"32918_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1124\/mol.106.025536","volume":"70","author":"L Chen","year":"2006","unstructured":"Chen, L. et al. Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor. Mol. Pharmacol. 70, 562\u2013570 (2006).","journal-title":"Mol. Pharmacol."},{"key":"32918_CR34","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1016\/j.bmcl.2011.05.078","volume":"21","author":"ZH Yu","year":"2011","unstructured":"Yu, Z. H. et al. Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening. Bioorg. Med. Chem. Lett. 21, 4238\u20134242 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"32918_CR35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bcp.2010.05.019","volume":"80","author":"L Chen","year":"2010","unstructured":"Chen, L. et al. Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112. Biochem. Pharmacol. 80, 801\u2013810 (2010).","journal-title":"Biochem. Pharmacol."},{"key":"32918_CR36","doi-asserted-by":"publisher","first-page":"NA","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, NA\u2013NA (2009).","journal-title":"J. Comput. Chem."},{"key":"32918_CR37","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 to promote a negative-feedback loop that attenuates phosphoinositide 3-Kinase\/Akt Signaling. Mol. Cell. Biol. 37, e00357-16 (2017).","DOI":"10.1128\/MCB.00357-16"},{"key":"32918_CR38","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/2211-5463.12992","volume":"10","author":"X Yue","year":"2020","unstructured":"Yue, X., Han, T., Hao, W., Wang, M. & Fu, Y. SHP2 knockdown ameliorates liver insulin resistance by activating IRS\u22122 phosphorylation through the AKT and ERK1\/2 signaling pathways. FEBS Open Biol. 10, 2578\u20132587 (2020).","journal-title":"FEBS Open Biol."},{"key":"32918_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1128\/MCB.01661-08","volume":"29","author":"F Princen","year":"2009","unstructured":"Princen, F. et al. Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death. Mol. Cell. Biol. 29, 378\u2013388 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"32918_CR40","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1073\/pnas.0811715106","volume":"106","author":"SS Zhang","year":"2009","unstructured":"Zhang, S. S. et al. Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic \u03b2-cells. Proc. Natl Acad. Sci. U. S. A. 106, 7531\u20137536 (2009).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"32918_CR41","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/ajmg.a.62039","volume":"185","author":"RM Noronha","year":"2021","unstructured":"Noronha, R. M. et al. Noonan syndrome patients beyond the obvious phenotype: A potential unfavorable metabolic profile. Am. J. Med. Genet. Part A 185, 774\u2013780 (2021).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"32918_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.apsb.2018.08.009","volume":"9","author":"M Zhao","year":"2019","unstructured":"Zhao, M. et al. SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade. Acta Pharm. Sin. B 9, 304\u2013315 (2019).","journal-title":"Acta Pharm. Sin. B"},{"key":"32918_CR43","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1038\/s41388-020-01488-5","volume":"39","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer. Oncogene 39, 7166\u20137180 (2020).","journal-title":"Oncogene"},{"key":"32918_CR44","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1172\/JCI130520","volume":"129","author":"R Pandey","year":"2019","unstructured":"Pandey, R. et al. SHP2 inhibition reduces leukemogenesis in models of combined genetic and epigenetic mutations. J. Clin. Investig. 129, 5468\u20135473 (2019).","journal-title":"J. Clin. Investig."},{"key":"32918_CR45","doi-asserted-by":"publisher","first-page":"x21","DOI":"10.1093\/annonc\/mdz440","volume":"30","author":"SE Nunnery","year":"2019","unstructured":"Nunnery, S. E. & Mayer, I. A. Management of toxicity to isoform \u03b1-specific PI3K inhibitors. Ann. Oncol. J. Eur. Soc. Med. Oncol. 30, x21\u2013x26 (2019).","journal-title":"Ann. Oncol. J. Eur. Soc. Med. Oncol."},{"key":"32918_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2020.11.007","volume":"62","author":"DL Kerr","year":"2021","unstructured":"Kerr, D. L., Haderk, F. & Bivona, T. G. Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment. Curr. Opin. Chem. Biol. 62, 1\u201312 (2021).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"32918_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"32918_CR48","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. Sect. D. Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"32918_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"32918_CR50","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/cmdc.201500015","volume":"10","author":"S Grosskopf","year":"2015","unstructured":"Grosskopf, S. et al. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo. ChemMedChem 10, 815\u2013826 (2015).","journal-title":"ChemMedChem"},{"key":"32918_CR51","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: Recent developments in Phenix. Acta Crystallogr. Sect. D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. Sect. D. Struct. Biol."},{"key":"32918_CR52","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"32918_CR53","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: Fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"32918_CR54","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1021\/ct300874c","volume":"9","author":"MM Reif","year":"2013","unstructured":"Reif, M. M., Winger, M. & Oostenbrink, C. Testing of the GROMOS force-field parameter set 54A8: Structural properties of electrolyte solutions, lipid bilayers, and proteins. J. Chem. Theory Comput. 9, 1247\u20131264 (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"32918_CR55","doi-asserted-by":"crossref","unstructured":"Trellet, M., Melquiond, A.S.J. & Bonvin, Alexandre, M.J.J. A unified conformational selection and induced fit approach to protein-peptide docking. PLoS One 8, e58769 (2013).","DOI":"10.1371\/journal.pone.0058769"},{"key":"32918_CR56","doi-asserted-by":"crossref","unstructured":"Margreitter, C., Petrov, D. & Zagrovic, B. Vienna-PTM web server: a toolkit for MD simulations of protein post-translational modifications. Nucleic Acids Res. 41, 422\u2013426 (2013).","DOI":"10.1093\/nar\/gkt416"},{"key":"32918_CR57","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"32918_CR58","doi-asserted-by":"publisher","first-page":"W464","DOI":"10.1093\/nar\/gkx238","volume":"45","author":"I Krystkowiak","year":"2017","unstructured":"Krystkowiak, I. & Davey, N. E. SLiMSearch: a framework for proteome-wide discovery and annotation of functional modules in intrinsically disordered regions. Nucleic Acids Res. 45, W464\u2013W469 (2017).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32918-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32918-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32918-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T11:13:07Z","timestamp":1663326787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32918-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32918"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32918-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5439"}}